tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

TGTX Stock Latest News

TG Therapeutics Reports Strong Revenue and Future Goals
Company AnnouncementsTG Therapeutics Reports Strong Revenue and Future Goals
4d ago
8K
TGTX
TG Therapeutics sees Q4 BRIUMVI U.S. net product revenue $103.6M
PremiumThe Fly
TG Therapeutics sees Q4 BRIUMVI U.S. net product revenue $103.6M
4d ago
TGTX
TG Therapeutics targets FY25 global revenue $540M, consensus $537.84M
PremiumThe Fly
TG Therapeutics targets FY25 global revenue $540M, consensus $537.84M
4d ago
TGTX
TG Therapeutics price target raised to $10 from $9 at BofA
PremiumThe Fly
TG Therapeutics price target raised to $10 from $9 at BofA
11d ago
TGTX
TG Therapeutics price target raised to $43 from $30 at JPMorgan
PremiumThe Fly
TG Therapeutics price target raised to $43 from $30 at JPMorgan
2M ago
TGTX
Unusually active option classes on open November 14th
PremiumThe FlyUnusually active option classes on open November 14th
2M ago
AAP
DIS
Reporters tweets about ‘vague whispers’ of bid interest in TG Therapeutics
Premium
The Fly
Reporters tweets about ‘vague whispers’ of bid interest in TG Therapeutics
2M ago
AZN
GSK
TG Therapeutics call volume above normal and directionally bullish
Premium
The Fly
TG Therapeutics call volume above normal and directionally bullish
2M ago
TGTX
TG Therapeutics call volume above normal and directionally bullish
PremiumThe Fly
TG Therapeutics call volume above normal and directionally bullish
2M ago
TGTX
TG Therapeutics price target raised to $45 from $43 at Ladenburg
PremiumThe Fly
TG Therapeutics price target raised to $45 from $43 at Ladenburg
2M ago
TGTX
TG Therapeutics Boosts Revenue Outlook Amidst Growth
PremiumCompany Announcements
TG Therapeutics Boosts Revenue Outlook Amidst Growth
2M ago
TGTX
B. Riley remains a buyer of TG Therapeutics on weakness following Q3 results
PremiumThe Fly
B. Riley remains a buyer of TG Therapeutics on weakness following Q3 results
2M ago
TGTX
TG Therapeutics price target raised to $55 from $49 at H.C. Wainwright
PremiumThe FlyTG Therapeutics price target raised to $55 from $49 at H.C. Wainwright
2M ago
TGTX
Morning Movers: Air Transport Services jumps following $3.1B take-private deal
Premium
The Fly
Morning Movers: Air Transport Services jumps following $3.1B take-private deal
2M ago
CC
CEG
TG Therapeutics reports Q3 EPS 2c, consensus 3c
Premium
The Fly
TG Therapeutics reports Q3 EPS 2c, consensus 3c
3M ago
TGTX
TG Therapeutics sees FY24 BRIUMVI U.S. revenue target $300M-$305M
PremiumThe Fly
TG Therapeutics sees FY24 BRIUMVI U.S. revenue target $300M-$305M
3M ago
TGTX
TGTX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
TGTX Earnings this Week: How Will it Perform?
3M ago
TGTX
TG Therapeutics initiated with a Buy at TD Cowen
PremiumThe Fly
TG Therapeutics initiated with a Buy at TD Cowen
3M ago
TGTX
TG Therapeutics price target raised to $38 from $34 at B. Riley
PremiumThe Fly
TG Therapeutics price target raised to $38 from $34 at B. Riley
3M ago
TGTX
TG Therapeutics call volume above normal and directionally bullish
PremiumThe FlyTG Therapeutics call volume above normal and directionally bullish
3M ago
TGTX
TG Therapeutics presents updated data from ENHANCE Phase 3b trial of BRIUMVI
Premium
The Fly
TG Therapeutics presents updated data from ENHANCE Phase 3b trial of BRIUMVI
4M ago
TGTX
TG Therapeutics announces updated data on five-year data from ULTIMATE trials
Premium
The Fly
TG Therapeutics announces updated data on five-year data from ULTIMATE trials
4M ago
TGTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >